EARLY SECOND TRIMESTER DYSLIPIDEMIA FOR PREDICTION OF OCCURRENCE OF PREECLAMPSIA | ||
| ALEXMED ePosters | ||
| Article 1, Volume 5, Issue 3, September 2023, Pages 58-59 | ||
| Document Type: Preliminary preprint short reports of original research | ||
| DOI: 10.21608/alexpo.2023.237290.1697 | ||
| Authors | ||
| Mohamed Abdelmoety Elsamra1; Samir Elsaid2; Raghda Saad Zaghloul3; Aya Ali Fouad Elsayed* 1 | ||
| 1Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University | ||
| 2Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Egypt | ||
| 3Department of Clinical & chemical Patholohy**, Faculty of Medicine, Alexandria University, Egypt | ||
| Abstract | ||
| Pregnancy-related hypertensive disorders are still a major global health concern for both mothers and their unborn children. Preeclampsia is defined: systolic blood pressure (SBP) greater than or equal to 140 mm Hg, diastolic blood pressure (DBP) more than or equal to 90 mm Hg, on two occasions as a minimum four hours apart in a patient who was previously normotensive patient and the co-occurrence of one or both of the resulting new-onset conditions: • Urine protein: creatinine ratio ≥30 mg/mmol. • Additional signs of maternal organ dysfunction, such as involvement of the kidneys or the liver, neurological or hemorrhagic issues, or uteroplacental dysfunction. Lipid metabolic abnormalities have been identified as possible risk factors for the onset and progression of preeclampsia. These risk variables are also present in arthrosclerosis, which may indicate a shared pathogenesis. The pathophysiology and development of preeclampsia are significantly influenced by lipids and lipid metabolism, including: • Vascular dysfunction • Defective trophoplastic invasion • Triggering inflammatory processes • Driving ferroptosis | ||
| Keywords | ||
| EARLY SECOND TRIMESTER; DYSLIPIDEMIA; PREECLAMPSIA | ||
|
Supplementary Files
|
||
|
Statistics Article View: 49 |
||
